Ann: Clinical Trial Preliminary Outcomes, page-187

The questions you pose are no doubt important. However for the average investor of which I am one it would be difficult to imagine understanding the research, especially without a simple conclusion. Brainwave frequency physiology, its relevance across the ASD, EEG technology etc. is a lifetime of work for some.

So for me I have to invest in the story, the people, the company structure and try and understand some of the basics.

Perhaps what @jeans_sammy is relating to is the market reaction. Yesterday the market liked what it saw. Today a decent sell off but the volume half and much of the volume earlier in the day. Todays price action was in the shadow of Wednesday's candle, hopefully 25c will provide support. For many investors reading the market reaction and understanding the company structure is all you can do with such complex products.

Tomorrow will be interesting.